mizoribine has been researched along with Berger Disease in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (10.34) | 18.2507 |
| 2000's | 11 (37.93) | 29.6817 |
| 2010's | 13 (44.83) | 24.3611 |
| 2020's | 2 (6.90) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, H; Ikezumi, Y; Kaneko, M; Kondoh, T; Kumagai, N; Matsumoto, Y; Nikolic-Paterson, DJ; Suzuki, T; Yamada, T; Yoshikane, M | 1 |
| Craig, JC; Molony, DA; Natale, P; Palmer, SC; Ruospo, M; Saglimbene, VM; Samuels, JA; Schena, FP; Strippoli, GF; Vecchio, M | 1 |
| Hosoya, M; Kawasaki, Y; Maeda, R; Ohara, S; Suyama, K | 1 |
| Hataya, H; Honda, M; Iijima, K; Ishikura, K; Kaku, Y; Matsuyama, T; Nakanishi, K; Nozu, K; Sako, M; Shima, Y; Tanaka, R; Yoshikawa, N | 1 |
| Iino, Y; Kaneko, T; Katayama, Y; Shimizu, A; Tsuruoka, S | 1 |
| Hashimoto, K; Hosoya, M; Kanno, S; Kawasaki, Y; Miyazaki, K; Ono, A; Sato, M; Suyama, K; Suzuki, Y | 1 |
| Fukui, M; Kaneko, T; Mii, A; Nagahama, K; Shimizu, A; Tsuruoka, S | 1 |
| Arai, M; Hirama, A; Ikeda, M; Kaneko, T; Morita, M; Shimizu, A; Tsuruoka, S; Watanabe, Y | 1 |
| Hirakata, H; Hirakawa, M; Katafuchi, R; Kitazono, T; Masutani, K; Mitsuiki, K; Tsuchimoto, A; Tsuruya, K; Yamada, T | 1 |
| Nakanishi, K; Nozu, K; Okamoto, M; Yokoyama, N; Yoshikawa, N | 1 |
| Yoshikawa, N | 1 |
| Abe, H; Furuno, Y; Kabashima, N; Matsumoto, M; Miyamoto, T; Miyazaki, M; Nakamata, J; Okazaki, M; Otsuji, Y; Serino, R; Shibata, T; Takeuchi, M; Tamura, M; Tokunaga, M | 1 |
| Kawasaki, Y | 1 |
| Iijima, K; Kamei, K; Nakanishi, K; Nozu, K; Sasaki, S; Shima, Y; Tanaka, R; Togawa, H; Yoshikawa, N | 1 |
| Fujino, T; Hirama, A; Iino, Y; Kaneko, T; Katayama, Y; Ueda, K; Utsumi, K | 1 |
| Chen, P; Chen, X; Huang, S; Li, Y; Lie, C; Liu, S; Miao, L; Wang, L; Wu, X; Xie, Y; Zhang, A | 1 |
| Aoki, M; Arakawa, Y; Arima, R; Fujita, E; Fukuda, K; Fukui, M; Hirama, A; Iino, Y; Kaneko, T; Mii, A; Shimizu, A; Utsumi, K | 1 |
| Degrell, P; Késoi, I; Kovács, T; Nagy, J; Sági, B; Vas, T; Wittmann, I | 1 |
| Kaneko, K; Nagaoka, R; Ohtomo, Y; Shimizu, T; Yamashiro, Y | 1 |
| Ikeda, M; Kuwajima, H; Okada, M; Sugimoto, K; Takemura, T; Yagi, K; Yanagida, H | 1 |
| Kumasaka, R; Nakamura, M; Nakamura, N; Shimada, M; Tsunoda, S; Yamabe, H | 1 |
| Ikezumi, Y; Karasawa, T; Kawachi, H; Nikolic-Paterson, DJ; Suzuki, T; Uchiyama, M | 1 |
| Hataya, H; Honda, M; Iijima, K; Ishikura, K; Nakanishi, K; Yoshikawa, N | 1 |
| Endo, T; Horata-Takahashi, E; Kamata, K; Kobayashi, Y; Kumano, K; Nakayama, Y; Okubo, M; Osakabe, T; Sato, K; Tamura, K | 1 |
| Abe, M; Shimizu, M; Shou, I; Tomino, Y; Tsuge, T | 1 |
| Kaneko, K; Nagaoka, R; Ohtomo, Y; Yamashiro, Y | 2 |
| Honda, K; Ishikawa, N; Nihei, H; Shimizu, T; Suzuki, K; Tanabe, K; Tokumoto, T; Toma, H; Yagisawa, T | 1 |
| Ebihara, I; Koide, H; Nakamura, T; Sekizuka, K; Shimada, N; Suzuki, S; Ushiyama, C | 1 |
5 review(s) available for mizoribine and Berger Disease
| Article | Year |
|---|---|
Immunosuppressive agents for treating IgA nephropathy.
Topics: Adult; Calcineurin Inhibitors; Cause of Death; Child; Confidence Intervals; Creatinine; Drug Administration Schedule; Drug Therapy, Combination; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Leflunomide; Mycophenolic Acid; Proteinuria; Randomized Controlled Trials as Topic; Remission Induction; Ribonucleosides; Risk; Steroids | 2020 |
[Treatment of childhood IgA nephropathy].
Topics: Azathioprine; Child; Dipyridamole; Drug Therapy, Combination; Evidence-Based Medicine; Glomerulonephritis, IGA; Heparin; Humans; Practice Guidelines as Topic; Prednisolone; Prognosis; Randomized Controlled Trials as Topic; Ribonucleosides; Warfarin | 2008 |
Mizoribine: a new approach in the treatment of renal disease.
Topics: Adolescent; Adult; Child; Female; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Kidney Diseases; Lupus Nephritis; Middle Aged; Nephrotic Syndrome; Ribonucleosides; Treatment Outcome | 2009 |
[Therapy in IgA nephropathy--when and how to do it].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Autoantibodies; Autoantigens; Cyclosporine; Glomerular Mesangium; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Immunoglobulin G; Immunosuppressive Agents; Mycophenolic Acid; Ribonucleosides | 2011 |
Mesangial immunoglobulin A deposition and focal glomerulosclerosis in a renal transplant patient with nephrotic syndrome--Berger's disease alone or superimposition of focal glomerulosclerosis?
Topics: Cyclosporine; Diagnosis, Differential; Female; Glomerular Mesangium; Glomerulonephritis; Glomerulonephritis, IGA; Glomerulosclerosis, Focal Segmental; Humans; Immunoglobulin A; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Nephrotic Syndrome; Prednisolone; Ribonucleosides | 1993 |
5 trial(s) available for mizoribine and Berger Disease
| Article | Year |
|---|---|
Combination therapy with or without warfarin and dipyridamole for severe childhood IgA nephropathy: an RCT.
Topics: Adolescent; Biopsy; Child; Dipyridamole; Drug Therapy, Combination; Female; Glomerular Mesangium; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Male; Prednisolone; Prospective Studies; Proteinuria; Ribonucleosides; Severity of Illness Index; Treatment Outcome; Warfarin | 2018 |
Comparison of steroid-pulse therapy and combined with mizoribine in IgA nephropathy: a randomized controlled trial.
Topics: Adult; Blood Pressure; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Male; Methylprednisolone; Middle Aged; Prospective Studies; Proteinuria; Ribonucleosides | 2016 |
Efficacy and safety of mizoribine combined with losartan in the treatment of IgA nephropathy: a multicenter, randomized, controlled study.
Topics: Adult; Angiotensin Receptor Antagonists; Blood Pressure; China; Creatinine; Drug Synergism; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Longitudinal Studies; Losartan; Male; Prospective Studies; Proteinuria; Ribonucleosides; Treatment Outcome; Uric Acid | 2011 |
Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy.
Topics: Adolescent; Adult; Age of Onset; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Child; Child, Preschool; Dipyridamole; Drug Therapy, Combination; Female; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Kidney; Male; Prednisone; Proteinuria; Ribonucleosides; Treatment Outcome; Vasodilator Agents | 2003 |
Combination therapy with mizoribine for severe childhood IgA nephropathy: a pilot study.
Topics: Biopsy; Child; Dipyridamole; Disease Progression; Female; Follow-Up Studies; Glomerulonephritis, IGA; Glucocorticoids; Humans; Immunoglobulin A; Immunosuppressive Agents; IMP Dehydrogenase; Kidney Glomerulus; Male; Pilot Projects; Platelet Aggregation Inhibitors; Prednisolone; Prospective Studies; Proteinuria; Ribonucleosides; Severity of Illness Index; Treatment Outcome | 2008 |
19 other study(ies) available for mizoribine and Berger Disease
| Article | Year |
|---|---|
Mizoribine halts kidney fibrosis in childhood IgA nephropathy: association with modulation of M2-type macrophages.
Topics: Child; Fibrosis; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Kidney Glomerulus; Macrophages; Prednisolone; Retrospective Studies | 2023 |
Serum IgA/C3 and glomerular C3 staining predict severity of IgA nephropathy.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Biopsy; Child; Complement C3; Dilazep; Female; Glomerulonephritis, IGA; Glucocorticoids; Humans; Immunoglobulin A; Kidney Function Tests; Kidney Glomerulus; Male; Prednisolone; Prognosis; Retrospective Studies; Ribonucleosides; Vasodilator Agents; Warfarin | 2018 |
Efficacy of steroid pulse therapy in combination with mizoribine following tonsillectomy for immunoglobulin A nephropathy in renally impaired patients.
Topics: Adult; Analysis of Variance; Chi-Square Distribution; Combined Modality Therapy; Drug Therapy, Combination; Glomerular Filtration Rate; Glomerulonephritis, IGA; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney; Methylprednisolone; Middle Aged; Pulse Therapy, Drug; Retrospective Studies; Ribonucleosides; Time Factors; Tonsillectomy; Treatment Outcome | 2013 |
Resistance factors for the treatment of immunoglobulin A nephropathy with diffuse mesangial proliferation.
Topics: Age of Onset; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biopsy; Calgranulin A; Calgranulin B; Child; Dilazep; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Immunosuppressive Agents; Japan; Kidney Function Tests; Male; Mesangial Cells; Prednisolone; Retrospective Studies; Ribonucleosides; Risk Factors; Severity of Illness Index; Vasodilator Agents | 2014 |
IgA nephropathy and psoriatic arthritis that improved with steroid pulse therapy and mizoribine in combination with treatment for chronic tonsillitis and epipharyngitis.
Topics: Aged; Anti-Bacterial Agents; Arthritis, Psoriatic; Chronic Disease; Combined Modality Therapy; Glomerulonephritis, IGA; Humans; Male; Pharyngitis; Proteinuria; Pulse Therapy, Drug; Ribonucleosides; Steroids; Tonsillitis; Treatment Outcome | 2015 |
Comparison of immunosuppressive therapies for IgA nephropathy after tonsillectomy: three-course versus one-course steroid pulse combined with mizoribine.
Topics: Adult; Anti-Inflammatory Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Hematuria; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Prednisolone; Proteinuria; Ribonucleosides; Tonsillectomy; Young Adult | 2015 |
Crescentic IgA nephropathy in a child: Effect of a new combination therapy.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Child; Drug Therapy, Combination; Glomerulonephritis, IGA; Humans; Lisinopril; Male; Prednisolone; Ribonucleosides; Valsartan | 2017 |
Mizoribine for relapsed proteinuria in an adult IgA nephropathy patient.
Topics: Dose-Response Relationship, Drug; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Male; Middle Aged; Proteinuria; Recurrence; Ribonucleosides | 2008 |
Disappearance of glomerular IgA deposits in childhood IgA nephropathy showing diffuse mesangial proliferation after 2 years of combination/prednisolone therapy.
Topics: Anti-Inflammatory Agents; Anticoagulants; Azathioprine; Child; Dipyridamole; Drug Therapy, Combination; Female; Glomerular Mesangium; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Immunosuppressive Agents; Kidney Glomerulus; Male; Prednisolone; Retrospective Studies; Ribonucleosides; Survival Rate; Treatment Outcome; Vasodilator Agents; Warfarin | 2011 |
Methylprednisolone pulse therapy combined with mizoribine following tonsillectomy for immunoglobulin A nephropathy: clinical remission rate, steroid sparing effect, and maintenance of renal function.
Topics: Adolescent; Adult; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Glucocorticoids; Humans; Immunosuppressive Agents; Japan; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Male; Methylprednisolone; Middle Aged; Pulse Therapy, Drug; Remission Induction; Retrospective Studies; Ribonucleosides; Tonsillectomy; Treatment Outcome; Young Adult | 2011 |
[Two cases of rapidly progressive nephritic syndrome complicated with alcoholic liver cirrhosis].
Topics: Adult; Disease Progression; Drug Therapy, Combination; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Immunosuppressive Agents; Kidney Glomerulus; Liver Cirrhosis, Alcoholic; Male; Methylprednisolone; Middle Aged; Prednisolone; Pulse Therapy, Drug; Ribonucleosides; Treatment Outcome | 2011 |
Effect of mizoribine on IL-6 release by peripheral blood mononuclear cells.
Topics: Adolescent; Child; Child, Preschool; Female; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Interleukin-6; Leukocytes, Mononuclear; Male; Ribonucleosides | 2002 |
Mizoribine decreases urinary protein excretion in two patients with IgA nephropathy.
Topics: Adult; Female; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Middle Aged; Proteinuria; Ribonucleosides | 2005 |
Use of mizoribine as a rescue drug for steroid-resistant pediatric IgA nephropathy.
Topics: Adolescent; Child; Drug Resistance; Female; Glomerulonephritis, IGA; Hematuria; Humans; Immunosuppressive Agents; Kidney; Macrophage Activation; Methylprednisolone; Prednisolone; Proteinuria; Ribonucleosides; Treatment Outcome | 2008 |
Effect of mizoribine on glomerulonephritis of early-stage IgA nephropathy in ddY mice.
Topics: Animals; B-Lymphocytes; Disease Models, Animal; Flow Cytometry; Glomerular Mesangium; Glomerulonephritis; Glomerulonephritis, IGA; Immunoglobulin A; Immunohistochemistry; Immunosuppressive Agents; Mice; Mice, Inbred Strains; Proteinuria; Ribonucleosides | 1998 |
Mizoribine for childhood IgA nephropathy.
Topics: Adolescent; Child; Child, Preschool; Female; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Male; Proteinuria; Ribonucleosides | 1999 |
Effect of tacrolimus in renal transplant recipients with immunoglobulin-A nephropathy.
Topics: Adult; Azathioprine; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerulonephritis, IGA; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Recurrence; Retrospective Studies; Ribonucleosides; Survival Rate; Tacrolimus; Time Factors | 2000 |
Effect of mizoribine on serum IgE concentration in patients with IgA nephropathy.
Topics: Adult; Case-Control Studies; Female; Glomerulonephritis, IGA; Humans; Immunoglobulin E; Immunosuppressive Agents; Male; Proteinuria; Ribonucleosides; T-Lymphocytes | 2001 |
Mizoribine treatment for childhood IgA nephropathy.
Topics: Adolescent; Female; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Male; Ribonucleosides; Time Factors | 2002 |